Shwe T, Khin M, Min H, Hla K K, Win Y Y, Htwe K, Thu T M
Clinical Research Unit (Cerebral and Complicated Malaria), Department of Medical Research, Yangon, Myanmar.
Southeast Asian J Trop Med Public Health. 1998 Mar;29(1):46-9.
Ten patients with uncomplicated malaria, ten with cerebral malaria and 37 controls (blood donors from blood bank) were included in the study. The serum cortisol levels of the patients were determined daily for 7 days while they were at the hospital. A radio-immunoassay method was used for quantitative measurement of cortisol in human serum. The mean serum cortisol level of patients with uncomplicated malaria was 528.2 +/- 123.9 nmol/l, with cerebral malaria was 516.0 +/- 80.5 nmol/l, and in controls was 393.8 +/- 141.0 nmol/l. There was a significant rise of serum cortisol levels in patients with malaria when compared to controls at the day of admission to hospital. There was no significant difference between uncomplicated malaria patients and those with cerebral malaria. There was also no significant difference between the different days of treatment up till day 7. We found no cortisol insufficiency in cases with falciparum malaria during acute and convalescent stages of illness.
该研究纳入了10例非复杂性疟疾患者、10例脑型疟疾患者和37名对照者(血库的献血者)。患者在住院期间连续7天每日测定血清皮质醇水平。采用放射免疫分析法对人血清中的皮质醇进行定量测定。非复杂性疟疾患者的血清皮质醇平均水平为528.2±123.9nmol/L,脑型疟疾患者为516.0±80.5nmol/L,对照者为393.8±141.0nmol/L。与对照组相比,疟疾患者入院当天血清皮质醇水平显著升高。非复杂性疟疾患者与脑型疟疾患者之间无显著差异。直至第7天的不同治疗日之间也无显著差异。我们发现在恶性疟急性和恢复期病例中不存在皮质醇不足的情况。